Michael Lawrence
PhD
Group Leader in Cancer Genomics
👥Biography 个人简介
Michael Lawrence developed MutSig and MutSigCV, the most widely used statistical methods for identifying significantly mutated cancer driver genes from whole-exome and whole-genome sequencing data, introducing critical corrections for gene-specific mutation rate variation that dramatically reduced false-positive driver gene calls. His work at the Broad Institute has defined the statistical framework for distinguishing driver from passenger mutations in cancer genomes and has been applied across all TCGA cancer types to build the comprehensive catalogue of cancer driver genes. His methods remain the standard for cancer driver gene discovery in large-scale sequencing studies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Michael Lawrence 的研究动态
Follow Michael Lawrence's research updates
留下邮箱,当我们发布与 Michael Lawrence(Broad Institute of MIT and Harvard)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment